autologous tumor vaccination

2 trials

Sponsors

Tokyo Womens Medical University, University of Tsukuba

Conditions

Glioblastoma

Phase 1

Phase I/IIa trial of autologous tumor vaccination in patients with primary glioblastoma

Active, not recruitingJPRN-C000000002

Tokyo Womens Medical UniversityGlioblastoma

Start: 2005-07-01Target: 25Updated: 2026-06-29

Phase I/IIa trial of autologous tumor vaccine and temozolomide administration in patients with primary glioblastoma

Active, not recruitingJPRN-UMIN000001426

University of TsukubaGlioblastoma

Start: 2008-10-01Target: 25Updated: 2026-06-29

Related Papers

Phase I/IIa trial of fractionated radiotherapy, temozolomide, and autologous formalin-fixed tumor vaccine for newly diagnosed glioblastoma

Journal of neurosurgery2014-07-0460 citations

Phase I/IIa trial of chemoradiotherapy plus autologous formalin-fixed tumor vaccine for newly diagnosed glioblastoma: Association between complete resection and delayed-type hypersensitivity response.

Journal of Clinical Oncology2014-05-201 citations